Your browser is no longer supported. Please, upgrade your browser.
HOLX [NASD]
Hologic, Inc.
IndexS&P 500 P/E18.10 EPS (ttm)4.20 Insider Own1.00% Shs Outstand259.91M Perf Week-5.45%
Market Cap18.95B Forward P/E16.10 EPS next Y4.73 Insider Trans-3.26% Shs Float255.37M Perf Month0.79%
Income1.12B PEG1.04 EPS next Q2.14 Inst Own97.00% Short Float1.86% Perf Quarter15.43%
Sales3.78B P/S5.02 EPS this Y671.70% Inst Trans0.10% Short Ratio2.47 Perf Half Y22.98%
Book/sh10.41 P/B7.31 EPS next Y-33.30% ROA16.40% Target Price87.31 Perf Year40.35%
Cash/sh2.82 P/C27.03 EPS next 5Y17.40% ROE48.00% 52W Range26.49 - 81.80 Perf YTD4.49%
Dividend- P/FCF22.59 EPS past 5Y56.10% ROI21.10% 52W High-6.97% Beta1.24
Dividend %- Quick Ratio1.50 Sales past 5Y6.90% Gross Margin59.70% 52W Low187.28% ATR2.40
Employees5814 Current Ratio1.80 Sales Q/Q55.50% Oper. Margin29.30% RSI (14)53.45 Volatility2.49% 3.11%
OptionableYes Debt/Eq1.13 EPS Q/Q509.40% Profit Margin29.50% Rel Volume0.54 Prev Close76.48
ShortableYes LT Debt/Eq1.01 EarningsJan 27 AMC Payout0.00% Avg Volume1.93M Price76.10
Recom1.80 SMA200.91% SMA504.27% SMA20023.18% Volume1,036,307 Change-0.50%
Nov-20-20Downgrade Needham Buy → Hold
Nov-05-20Reiterated Needham Buy $78 → $88
Jun-30-20Upgrade Cowen Market Perform → Outperform $64
Jun-03-20Upgrade Raymond James Mkt Perform → Outperform $62
Apr-30-20Upgrade SVB Leerink Mkt Perform → Outperform $62
Apr-30-20Reiterated Needham Buy $52 → $60
Apr-07-20Upgrade Wells Fargo Equal Weight → Overweight $48
Mar-27-20Upgrade Morgan Stanley Underweight → Equal-Weight $40
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $24
Jan-13-20Reiterated Needham Buy $57 → $62
Jan-08-20Initiated Wells Fargo Equal Weight $57
Jan-07-20Initiated Citigroup Buy $60
Jan-02-20Downgrade Evercore ISI Outperform → In-line
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $54 → $59
Aug-01-19Reiterated Needham Buy $52 → $57
May-02-19Reiterated Needham Buy $50 → $52
Jan-31-19Reiterated Needham Buy $48 → $50
Jan-02-19Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-09-18Initiated UBS Neutral
Sep-13-18Downgrade BofA/Merrill Buy → Neutral
Jan-15-21 10:25AM  
08:35AM  
Jan-14-21 05:50PM  
05:41PM  
12:16PM  
11:51AM  
11:30AM  
09:56AM  
09:46AM  
09:06AM  
Jan-13-21 09:52AM  
09:15AM  
Jan-12-21 07:38PM  
12:45PM  
08:40AM  
02:39AM  
Jan-11-21 02:18PM  
10:34AM  
10:12AM  
10:08AM  
09:55AM  
09:45AM  
08:32AM  
Jan-08-21 01:33PM  
12:42PM  
09:22AM  
09:02AM  
09:00AM  
08:30AM  
Jan-07-21 11:25AM  
Jan-06-21 03:24PM  
01:52PM  
01:30PM  
09:29AM  
07:30AM  
Jan-05-21 06:33PM  
04:22PM  
04:01PM  
01:36PM  
11:51AM  
10:15AM  
06:53AM  
Jan-04-21 02:04PM  
09:32AM  
08:05AM  
Dec-31-20 09:39AM  
09:26AM  
08:42AM  
Dec-30-20 08:37AM  
08:04AM  
Dec-29-20 10:36AM  
Dec-28-20 04:02PM  
02:00PM  
Dec-27-20 12:10PM  
Dec-24-20 01:37PM  
12:06PM  
Dec-23-20 03:16PM  
09:47AM  
08:21AM  
Dec-22-20 01:48PM  
12:48PM  
Dec-21-20 09:16AM  
Dec-18-20 05:02PM  
11:30AM  
10:55AM  
Dec-17-20 03:20PM  
08:15AM  
Dec-16-20 02:01PM  
01:58PM  
12:00PM  
09:54AM  
09:07AM  
09:01AM  
Dec-15-20 12:45PM  
09:07AM  
08:46AM  
08:38AM  
Dec-14-20 11:46AM  
10:46AM  
Dec-11-20 11:15AM  
09:53AM  
09:43AM  
09:35AM  
Dec-10-20 08:11PM  
11:34AM  
10:50AM  
Dec-09-20 09:30AM  
09:27AM  
08:22AM  
08:18AM  
Dec-08-20 12:52PM  
10:44AM  
10:18AM  
10:12AM  
10:00AM  
09:33AM  
Dec-07-20 12:02PM  
10:26AM  
09:53AM  
09:32AM  
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thornal Kevin RDiv. President, DiagnosticsDec 10Option Exercise38.6916,869652,65842,452Dec 14 04:44 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Sale73.9916,8691,248,21233,216Dec 14 04:44 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerDec 10Sale73.641,477108,75916,575Dec 14 04:41 PM
Griffin John M.General CounselNov 18Option Exercise39.9622,900915,084157,386Nov 20 04:12 PM
Griffin John M.General CounselNov 18Sale71.0822,9001,627,689134,486Nov 20 04:12 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Option Exercise26.215,000131,05023,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Sale72.585,000362,90018,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Option Exercise26.216,542171,46625,127Nov 16 04:24 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Sale70.606,542461,84618,585Nov 16 04:24 PM
GARRETT SCOTT TDirectorNov 09Option Exercise22.3511,146249,11362,531Nov 12 04:26 PM
Stamoulis ChristianaDirectorNov 04Option Exercise22.3511,146249,11350,538Nov 06 04:10 PM
Stamoulis ChristianaDirectorNov 04Sale74.0011,146824,80439,392Nov 06 04:10 PM
Oberton Karleen MarieChief Financial OfficerSep 22Option Exercise26.215,461143,13334,417Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Option Exercise26.2115,000393,15043,956Sep 23 04:21 PM
Oberton Karleen MarieChief Financial OfficerSep 21Sale62.5015,000937,50028,956Sep 23 04:21 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Option Exercise23.822,98671,12719,699Aug 05 05:49 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 03Sale71.244,924350,81016,713Aug 05 05:49 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Option Exercise26.2110,493275,02270,484Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthJun 30Sale54.0710,493567,35759,991Jul 02 04:04 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Option Exercise26.2110,493275,02270,484May 27 04:12 PM
Valenti Peter J. IIIDivision Pres., Breast HealthMay 22Sale51.8210,493543,77959,991May 27 04:12 PM
CRAWFORD SALLYDirectorMay 22Sale51.9931,9501,661,081126,847May 27 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Option Exercise26.0113,888361,22730,914May 19 04:09 PM
Thornal Kevin RDiv. President, DiagnosticsMay 15Sale51.5113,888715,42617,026May 19 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Option Exercise22.29215,9964,814,5511,913,438May 15 04:17 PM
MACMILLAN STEPHEN PChairman, President and CEOMay 13Sale50.97190,9969,735,2571,722,442May 15 04:17 PM
GARRETT SCOTT TDirectorMay 01Option Exercise20.3424,204492,30951,385May 05 04:16 PM
Griffin John M.General CounselApr 28Option Exercise32.384,906158,85698,080Apr 30 04:07 PM
Griffin John M.General CounselApr 28Sale50.004,906245,30095,307Apr 30 04:07 PM
CRAWFORD SALLYDirectorMar 09Option Exercise22.3511,146249,113169,943Mar 11 04:07 PM
CRAWFORD SALLYDirectorMar 09Sale44.0811,146491,317158,797Mar 11 04:07 PM
MACMILLAN STEPHEN PChairman, President and CEOFeb 03Option Exercise22.29215,9964,814,5511,891,838Feb 05 04:16 PM
MACMILLAN STEPHEN PChairman, President and CEOFeb 03Sale53.54194,39610,407,1841,697,442Feb 05 04:16 PM